HLS Therapeutics, Inc. (HLS.TO)
4.50
0.00 (0.00%)
CAD |
TSX |
Feb 20, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 140.73M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 8.43% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 1.825 |
| Price to Book Value | 1.638 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.8761 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 87.57% |
Profile
| HLS Therapeutics, Inc. engages in commercializing pharmaceutical products. It specializes in central nervous system and cardiovascular markets. The company was founded by Gregory Gubitz and Gilbert Godin on June 5, 2014 and is headquartered in Etobicoke, Canada. |
| URL | http://www.hlstherapeutics.com |
| Investor Relations URL | https://hlstherapeutics.investorroom.com/ |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 19, 2026 (est.) |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 27, 2023 |
Profile
| HLS Therapeutics, Inc. engages in commercializing pharmaceutical products. It specializes in central nervous system and cardiovascular markets. The company was founded by Gregory Gubitz and Gilbert Godin on June 5, 2014 and is headquartered in Etobicoke, Canada. |
| URL | http://www.hlstherapeutics.com |
| Investor Relations URL | https://hlstherapeutics.investorroom.com/ |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 19, 2026 (est.) |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 27, 2023 |